/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ffc38c78cb62b0af8718cd1/2022-03-31-10-13-12-514-62457eb8f636e9189415b127.jpg)
Please note: This article is the second in our HealthTech - Shifting Landscapes Series. For an introduction to this series, overview of...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-30-10-56-03-368-62443743f636e90d04c33305.jpg)
We stand today on the threshold of almost unimaginable progress in defeating diseases that have ravaged humans for millennia. New...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-29-13-00-40-512-624302f8f636e91b1c51ca80.jpg)
Along with the article about the ascension of FemTechs in the healthcare market, produced by the Life Sciences, Healthcare and Cannabis...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-28-10-41-49-744-624190edf636e91b1c500acc.jpg)
Patent term extensions (PTEs) in Australia have been a hot topic over the past year. On Friday, things got a lot hotter for patentees...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-25-10-33-28-288-623d9a78f636ea1ad4be7a40.jpg)
This Wednesday (March 23, 2022), the Brazilian Health Regulatory Agency (ANVISA) approved a Collegiate Board Resolution (RDC) which...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ffc38c78cb62b0af8718cd1/2022-03-18-17-08-27-165-6234bc8bf636ea069894befa.jpg)
After a lengthy industry consultation process by the Australian Therapeutic Goods Administration, the updated Therapeutic Goods...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-03-16-10-29-39-636-6231bc13f636ea1a7ccdc08c.jpg)
The Association of the British Pharmaceutical Industry (ABPI, the UK’s leading association for pharmaceutical companies), has published a...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-03-14-12-14-29-831-622f31a5f636e90d68f7c29c.jpg)
International Women's Day, celebrated every March 8, focuses on the achievements of women over the years in the cultural, political and...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-08-14-29-12-614-62276838f636e91924779089.jpg)
Experiencing a global pandemic has provided us with many examples of the importance of scientific research to our lives. Meanwhile, a...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-02-15-09-58-57-374-620b7961f636e91514425bb5.jpg)
HealthTech: Trends and Challenges In a recent internal webinar, DLA Piper and Global Data looked into the shifting landscape of...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-03-04-14-18-15-709-62221fa7f636e910dcb63426.jpg)
In a note published on 2 March 2022, the Italian Medicines Agency (AIFA) confirmed that all pharmaceutical companies must, by no later...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/612f875dfac91e13ac7ca0dd/2022-03-03-16-17-32-883-6220ea1cf636ea1b34561e58.jpg)
In late February, 2022 the US Food and Drug Administration (FDA) hosted a webinar detailing its current transition plans for medical...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-03-16-26-13-235-6220ec25f636ea12a42eddb8.jpg)
Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. In this episode, DLA...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-02-13-50-47-719-621f7637f636ea1798e82363.jpg)
In Europe, the unitary patent and the Unified Patent Court (UPC) have moved another step closer since Austria’s deposit of its...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-01-16-06-57-521-621e44a1f636e91a7002c58c.jpg)
The Spanish Data Protection Commissioner (“AEPD”) has recently approved the “Code of conduct regulating the processing of personal data...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-03-01-09-38-18-162-621de98af636ea1a608d7b35.jpg)
The Portuguese National Authority for Medicines and Health Products (“INFARMED”) and the Portuguese Environment Agency (“APA”) issued a...
